Health is Wealth

While the Benign Prostatic Hyperplasia Treatment Market is growing, several challenges remain. High treatment costs, especially for surgical procedures, limit accessibility in lower-income regions. Side effects of medications can lead to discontinuation, prompting the need for alternative therapies. In some countries, cultural stigma around men’s reproductive health discourages patients from seeking timely treatment. Regulatory delays for new devices and drugs also slow market entry. Addressing these barriers will require coordinated efforts from healthcare providers, policymakers, and industry players to ensure equitable access and encourage innovation.